Ami Miller

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• AstraZeneca (United Kingdom)9.6%
• Frederick National Laboratory for Cancer Research8.8%
• Centre National de la Recherche Scientifique8.5%
• Inserm8%
• NYU Langone Health7.6%
• Boehringer Ingelheim (Austria)6.8%
• Other50.8%

Fields

• Biochemistry, Genetics and Molecular Biology47.1%
• Medicine29.4%
• Immunology and Microbiology17.4%
• Computer Science3.1%
• Chemistry1%
• Materials Science1%
• Other1%

Topics

• Protein Kinase Regulation and GTPase Signaling20.5%
• Monoclonal and Polyclonal Antibodies Research8.9%
• Ubiquitin and proteasome pathways8.9%
• Protein Degradation and Inhibitors8.9%
• Complement system in diseases7.1%
• Melanoma and MAPK Pathways6.6%
• Other39.2%